A new topical treatment for resistant herpes simplex infections.
R
R
Snoeck
G
G
Andrei
E
E
De Clercq
M
M
Gerard
N
N
Clumeck
G
G
Tricot
C
C
Sadzot-Delvaux
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy; D000998:Antiviral Agents / Q000627:therapeutic use*; D000077404:Cidofovir; D003596:Cytosine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004351:Drug Resistance; D006561:Herpes Simplex / Q000188:drug therapy*; D006801:Humans; D016867:Immunocompromised Host; D063065:Organophosphonates; D009943:Organophosphorus Compounds / Q000627:therapeutic use*; D018139:Simplexvirus / Q000187:drug effects
D000998:Antiviral Agents; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D003596:Cytosine; D000077404:Cidofovir